Canadian Committee on Antibiotic Resistance report

Canadian Journal of Infectious Diseases

Volumn 15, Issue 5, 2004, Pages 257-260

  Conly, John M ^a   McEwen, Scott ^b   Hutchinson, Jim ^c   Boyd, Nora ^d   Callery, Sandra ^e   Bryce, Elizabeth ^f   Walter, Rick ^g  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

^c Health Sciences Centre St John's   (Canada)

^d Bluewater Health   (Canada)

^e ST JOSEPH S HOSPITAL   (Canada)

^f VANCOUVER GENERAL HOSPITAL   (Canada)

^g Canadian Committee on Antibiotic Resistance   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEPHALOSPORIN; TETRACYCLINE;

AGRICULTURE; ANTIBIOTIC RESISTANCE; ARTICLE; COST; DISEASE TRANSMISSION; DRUG MONITORING; DRUG USE; HUMAN; INFECTION; INFECTION CONTROL; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; STAPHYLOCOCCUS INFECTION;

EID: 9344246270     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/582574     Document Type: Article

References (20)

1. Canadian Committee on Antibiotic Resistance. 〈http://www.ccar-ccra. com/pdf/Action%20Plan.Sept2004.pdf〉 (Version current at September 29, 2004).
2. Canadian Integrated Program for Antimicrobial Resistance Surveillance. 〈http://www.hc-sc.gc.ca/pphb-dgspsp/cipars-picra/index.html〉 (Version current at September 9, 2004).
3. World Health Organization: Overcoming antimicrobial resistance. Report on infectious diseases 2000. 〈www.who.int/infectious-disease-report/2000/ index.html〉 (Version current at September 9, 2004).
4. American Society for Microbiology. Report of the ASM task force on antimicrobial resistance. Antimicrob Agents Chemother 1995;(Suppl):1-23.
5. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996;275:234-40.
6. Swartz MN. Use of antimicrobial agents and drug resistance. N Engl J Med 1997;337:491-2.
7. Kunin CM. Resistance to antimicrobial drugs - a worldwide calamity. Ann Intern Med 1993;118:557-61.
8. Centers for Disease Control and Prevention. Addressing emerging infectious disease threats: A prevention strategy for the United States. Executive summary. MMWR Recomm Rep 1994;43:1-18.
9. Central Intelligence Agency. The global infectious disease threat and its implications for the United States. 〈http://www.odci.gov/cia/reports/nie/ report/nie99-17d.html〉 (Version current at September 9, 2004).
10. Moberg CL. Rene Dubos: A harbinger of microbial resistance to antibiotics. Microb Drug Resist 1996;2:287-97.
11. Levy SB. Antibiotic resistance: An ecological imbalance. Ciba Found Symp 1997;207:1-14.
12. Conly J. Antimicrobial resistance in Canada. CMAJ 2002;167:885-91.
13. Palatnick B, Weshnoweski B, Bellyou T, Topnik D, Zhanel GG, Hoban D. Evaluation of antibiotic susceptibility in 17,585 respiratory tract infection pathogens collected across Canada from 1997-2002: Results of the Canadian respiratory organism susceptibility study (CROSS). The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, September 2003:E-2184. (Abst)
14. Scheffele D, Halperin S, Pelletier L, Talbot J. Invasive pneumococcal infections in Canadian children, 1991-1998: Implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT). Clin Infect Dis 2000;31:58-64.
15. IMS HEALTH Canada and Canadian Committee on Antibiotic Resistance. Antibiotic use data by region and by product class from 1996 to December 2000. 〈http://www.ccar-ccra.com/optimal-e.htm〉 (Version current at September 9, 2004).
16. Birnbaum D. Canadian Committee on Antibiotic Resistance. Antimicrobial resistance: A deadly burden no country can afford to ignore. Can Commun Dis Rep 2003;29:157-64.
17. Wiener J, Quinn JP, Bradford PA, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999;281:517-23.
18. Lucet JC, Deere D, Fichelle A, et al. Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital. Clin Infect Dis 1999;29:1411-8.
19. Johnston L, Ofner-Agostini M, Conly J, et al. Infection control strategies to prevent the transmission of vancomycin-resistant enterococci (VRE) in hospitals participating in the Canadian Nosocomial Infection Surveillance Program. 14th Annual Scientific Meeting, Society for Healthcare Epidemiology of America. Philadelphia, April 17-20, 2004:337 (Abst).
20. Per capita antibiotic consumption: How does a North American jurisdiction compare with Europe? 〈http://www.journals.uchi cago.edu/ClD/journal/ issues/v39n1/32888/brief/32888.abstract.html〉 (Version current at September 29, 2004)